Search

Bioprospect’s new board

Retiring Bioprospect chairman Winton Willesee has been replaced by Silvi Elkhouri as director and Peter May as non-executive chairman of the company.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byLedge Finance

Medibio (MEB)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/12/18

1 year TSR5 year TSR
thData Exchange Network
631stCAQ-52%-27%
638thLiveHire-54%
771stMyFiziq-74%
836thMedibio-93%-40%
716 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

09/11/18
$8k Bought
07/11/18
$4k Bought
06/11/18
$9k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

126th↓Medibio$2.5m
130th↑LiveHire$2.1m
131st↑MyFiziq$2.1m
133rd↑CAQ$2.0m
134th-Data Exchange Network$2.0m
237 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer